A transgenic mouse that spontaneously develops pathogenic TSH receptor antibodies will facilitate study of antigen-specific immunotherapy for human Graves’ disease
Crossref DOI link: https://doi.org/10.1007/s12020-019-02083-9
Published Online: 2019-09-27
Published Print: 2019-11
Update policy: https://doi.org/10.1007/springer_crossmark_policy
McLachlan, Sandra M.
Rapoport, Basil
Text and Data Mining valid from 2019-09-27
Version of Record valid from 2019-09-27
Article History
Received: 27 July 2019
Accepted: 4 September 2019
First Online: 27 September 2019
Compliance with ethical standards
:
: The authors declare that they have no conflict of interest.